Amy L. Dix, MPAS, PA-C, AQH, MSCS, Author at Clinical Advisor
Amy L. Dix, MPAS, PA-C, AQH, MSCS

Amy L. Dix, MPAS, PA-C, AQH, MSCS

Amy L. Dix, MPAS, PA-C, AQH, MSCS, is a PhD student at the University of NOVA Southeastern, Dr. Pallavi Patel College of Health Sciences. She is currently employed by EMD Serono, Inc.

All articles by Amy L. Dix, MPAS, PA-C, AQH, MSCS

The Role of Newer Abortive Agents

In December 2019, the US Food and Drug Administration (FDA) approved the first small molecule calcitonin gene-related peptide (CGRP) antagonist for the treatment of acute migraine, ubrogepant (Ubrelvy®),1 followed closely by rimegepant (Nurtec ODT®).2 A novel serotonin (5-HT)1F receptor agonist, lasmiditan (Reyvow®), was approved in October 2019 as a new oral agent for the acute…

Next post in Neurology Information Center